journal article·2014-02Open access

Therapeutic applications of low-toxicity spherical nanocarbon materials

Jing Wang, Zhongbo Hu, Jianxun Xu, Yuliang Zhao

NPG Asia Materials· Volume 6· Issue 2

Abstract

Nanocarbon materials have received considerable attention due to their unique structure and properties, which make them promising candidate materials for use in biomedical applications. In this review, we discuss the therapeutic applications of spherical nanocarbon materials, including fullerene nanoparticles, carbon nanohorn aggregates, nanodiamonds and porous carbon nanospheres, and their toxicology in biological systems. We put special emphasis on the antitumor effects of these multifunctional nanoparticles, which operate via novel mechanisms in a highly efficient manner. The low toxicities of these spherical nanocarbon materials as well as the possible effects of shape on toxicity are discussed. Various spherical nanocarbon materials, including fullerenes, carbon nanohorn aggregates, nanodiamonds etc., have shown potential anti-cancer effects. Fullerenes and metallofullerenes possess outstanding ROS-scavenging capability, as well as other biological effects like immunity enhancement etc., affording promising tumor suppression potential. Carbon nanohorn aggregates and nanodiamond particles have demonstrated effective drug delivery ability for cancer therapy. Moreover, it is noteworthy that these spherical nanocarbon materials show positive toxicological evaluation results, encouraging possible practical usage for biomedical applications. Since the discovery of fullerenes in 1985 with the report of a football-shaped C60 molecule, a variety of carbon nanostructures have emerged, the most familiar of which are carbon nanotubes and graphene sheets. Owing to some intriguing properties and an ever-increasing range of potential applications, these ‘nanocarbons’ have attracted a great deal of attention from the scientific and technology communities. Jianxun Xu and Yuliang Zhao from the National Center for Nanosciences and Technology, China, and co-workers review both the pharmaceutical activity and toxicity of spherical nanocarbons. Such materials—which include fullerenes, the ‘nanohorn’ clusters formed from aggregated horn-shaped carbon nanotubes, nanodiamonds and porous nanospheres—are less toxic than their non-spherical counterparts in biomedical applications. In particular, Xu, Zhao and colleagues focus on the potential of these species for anticancer treatments that arise from their effects, including tumor metastasis and drug-resistance suppression.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Fullerene Chemistry and Applications · Nanoparticles: synthesis and applications · Carbon Nanotubes in Composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Liu, Y. & Wang, H. Nanomedicine: nanotechnology tackles tumours. Nat. Nanotechnol. 2, 20–21 (2007).10.1038/nnano.2006.188 ↗
2. Shim, M. S. & Kwon, Y. J. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv. Drug Del. Rev. 64, 1046–1058 (2012).10.1016/j.addr.2012.01.018 ↗
3. Allen, T. M. & Cullis, P. R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).10.1126/science.1095833 ↗
4. Krauss, T. D. Biosensors: nanotubes light up cells. Nat. Nanotechnol. 4, 85–86 (2009).10.1038/nnano.2008.425 ↗
5. Jiang, H. J. Chemical preparation of graphene-based nanomaterials and their applications in chemical and biological sensors. Small 7, 2413–2427 (2011).10.1002/smll.201002352 ↗
6. Jans, H. & Huo, Q. Gold nanoparticle-enabled biological and chemical detection and analysis. Chem. Soc. Rev. 41, 2849–2866 (2012).10.1039/C1CS15280G ↗
7. Swierczewska, M., Choi, K. Y., Mertz, E. L., Huang, X. L., Zhang, F., Zhu, L., Yoon, H. Y., Park, J. H., Bhirde, A., Lee, S. & Chen, X. Y. A facile, one-step nanocarbon functionalization for biomedical applications. Nano Lett. 12, 3613–3620 (2012).10.1021/nl301309g ↗
8. Kam, N. W. S., Jessop, T. C., Wender, P. A. & Dai, H. Nanotube molecular transporters: internalization of carbon nanotube−protein conjugates into mammalian cells. J. Am. Chem. Soc. 126, 6850–6851 (2004).10.1021/ja0486059 ↗
9. Chen, Z., Tabakman, S. M., Goodwin, A. P., Kattah, M. G., Daranciang, D., Wang, X., Zhang, G., Li, X., Liu, Z., Utz, P. J., Jiang, K., Fan, S. & Dai, H. Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat. Biotechnol. 26, 1285–1292 (2008).10.1038/nbt.1501 ↗
10. Liu, Z., Davis, C., Cai, W., He, L., Chen, X. & Dai, H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA 105, 1410–1415 (2008).10.1073/pnas.0707654105 ↗
11. Valentini, F., Carbone, M. & Palleschi, G. Carbon nanostructured materials for applications in nano-medicine, cultural heritage, and electrochemical biosensors. Anal. Bioanal. Chem. 405, 451–465 (2013).10.1007/s00216-012-6351-6 ↗
12. Kostarelos, K., Bianco, A. & Prato, M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4, 627–633 (2009).10.1038/nnano.2009.241 ↗
13. Maeda-Mamiya, R., Noiri, E., Isobe, H., Nakanishi, W., Okamoto, K., Doi, K., Sugaya, T., Izumi, T., Homma, T. & Nakamura, E. In vivo gene delivery by cationic tetraamino fullerene. Proc. Natl Acad. Sci. USA 107, 5339–5344 (2010).10.1073/pnas.0909223107 ↗
14. Nakamura, E. & Isobe, H. In vitro and in vivo gene delivery with tailor-designed aminofullerenes. Chem. Rec. 10, 260–270 (2010).10.1002/tcr.201000021 ↗
15. Yamashita, T., Yamashita, K., Nabeshi, H., Yoshikawa, T., Yoshioka, Y., Tsunoda, S. & Tsutsumi, Y. Carbon nanomaterials: efficacy and safety for nanomedicine. Mater. 5, 350–363 (2012).10.3390/ma5020350 ↗
16. Chao, J., Perevedentseva, E., Chung, P., Liu, K., Cheng, C., Chang, C. & Cheng, C. Nanometer-sized diamond particle as probe for biolabeling. Biophys. J. 93, 2199–2208 (2007).10.1529/biophysj.107.108134 ↗
17. Krueger, A. New carbon materials: biological applications of funtionalized nanodiamond materials. Chem. Eur. J. 14, 1382–1390 (2008).10.1002/chem.200700987 ↗
18. Man, H. B. & Ho, D. Diamond as a nanomedical agent for versatile applications in drug delivery, imaging, and sensing. Phys. Status Solidi. A 209, 1609–1618 (2012).10.1002/pssa.201200470 ↗
19. Tang, L. A. L., Lee, W. C., Shi, H., Wong, E. Y. L., Sadovoy, A., Gorelik, S., Hobley, J., Lim, C. T. & Loh, K. P. Highly wrinkled cross-linked graphene oxide membranes for biological and charge-storage applications. Small 8, 423–431 (2012).10.1002/smll.201101690 ↗
20. Dong, H. Q., Li, Y. Y., Yu, J. H., Song, Y. Y., Cai, X. J., Liu, J. Q., Zhang, J. M., Ewing, R. C. & Shi, D. L. A versatile multicomponent assembly via -cyclodextrin hostguest chemistry on graphene for biomedical applications. Small 9, 446–456 (2013).10.1002/smll.201201003 ↗
21. Posthuma-Trumpie, G. A., Wichers, J. H., Koets, M., Berendsen, L. & Amerongen, A. Amorphous carbon nanoparticles: a versatile label for rapid diagnostic (immuno)assays. Anal. Bioanal. Chem. 402, 593–600 (2012).10.1007/s00216-011-5340-5 ↗
22. Yan, A., Lau, B. W., Weissman, B. S., Kulaots, I., Yang, N. Y. C., Kane, A. B. & Hurt, R. H. Biocompatible, hydrophilic supramolecular carbon nanoparticles for cell delivery. Adv. Mater. 18, 2373–2378 (2006).10.1002/adma.200600838 ↗
23. Bianco, A., Kostarelos, K. & Prato, M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin. Drug. Deliv. 5, 331–342 (2008).10.1517/17425247.5.3.331 ↗
24. Fisher, C., Rider, A. E., Han, Z. J., Kumar, S., Levchenko, I. & Ostrikov, K. Applications and nanotoxicity of carbon nanotubes and graphene in biomedicine. J. Nanomater. 2012, 315185 (2012).10.1155/2012/315185 ↗
25. Shinohara, H. Endohedral metallofullerenes. Rep. Prog. Phys. 63, 843–892 (2000).10.1088/0034-4885/63/6/201 ↗
26. Friedman, S. H., DeCamp, D. L., Sijbesma, R. P., Srdanov, G., Wudl, F. & Kenyon, G. L. Inhibition of the HIV- 1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115, 6506–6509 (1993).10.1021/ja00068a005 ↗
27. Sijbesma, R. P., Srdanov, G., Wudl, F., Castoro, J. A., Wilkins, C., Friedman, S. H., DeCamp, D. L. & Kenyon, G. L. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 115, 6510–6512 (1993).10.1021/ja00068a006 ↗
28. Partha, R. & Conyers, J. L. Biomedical applications of functionalized fullerene-based nanomaterials. Intl. J. Nanomed. 4, 261–275 (2009).10.2217/nnm.09.11 ↗
29. Xiao, L., Takada, H., Gan, X. & Miwa, N. The water-soluble fullerene derivative ‘Radical Sponge’ exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg. Med. Chem. Lett. 16, 1590–1595 (2006).10.1016/j.bmcl.2005.12.011 ↗
30. Sayes, C. M., Gobin, A. M., Ausman, K. D., Mendes, J., West, J. L. & Colvin, V. L. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterial 26, 7587–7595 (2005).10.1016/j.biomaterials.2005.05.027 ↗
31. Gharbi, N., Pressac, M., Hadchouel, M., Szwarc, H., Wilson, S. R. & Moussa, F. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 5, 2578–2585 (2005).10.1021/nl051866b ↗
32. Jensen, A. W., Wilson, S. R. & Schuster, D. I. Biological applications of fullerenes. Bioorg. Med. Chem. 4, 767–779 (1996).10.1016/0968-0896(96)00081-8 ↗
33. Wilson, L. J. Medical applications of fullerenes and metallofullerenes. Electrochem. Soc. Interface 8, 24–28 (1999).10.1149/2.F04994IF ↗
34. Tsai, M. C., Chen, Y. H. & Chiang, L. Y. Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. J. Pharm. Pharmacol. 49, 438–445 (1997).10.1111/j.2042-7158.1997.tb06821.x ↗
35. Bisaglia, M., Natalini, B., Pellicciari, R., Straface, E., Malorni, W., Monti, D., Franceschi, C. & Schettini, G. C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. J. Neurochem. 74, 1197–1204 (2000).10.1046/j.1471-4159.2000.741197.x ↗
36. Lai, H. S., Chen, W. J. & Chiang, L. Y. Free radical scavenging activity of fullerenol on the Ischemia-reperfusion intestine in dogs. World J. Surg. 24, 450–454 (2000).10.1007/s002689910071 ↗
37. Jain, K. K. The role of nanobiotechnology in drug discovery. Drug Discov. Today 10, 1435–1442 (2005).10.1016/S1359-6446(05)03573-7 ↗
38. Satoh, M. & Takayanag, I. Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives. J. Pharmacol. Sci. 100, 513–518 (2006).10.1254/jphs.CPJ06002X ↗
39. Djordjevic, A., Bogdanovic, G. & Dobric, S. Fullerenes in biomedicine. J. BUON. 11, 391–404 (2006).
40. Isakovic, A., Markovic, Z., TOdorovic-Markovic, B., Nikolic, N., Vranjes-Djuric, S., Mirkovic, M., Dramicanin, M., Harhaji, L., Raicevic, N., Nikolic, Z. & Trajkovic, V. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol. Sci. 91, 173–183 (2006).10.1093/toxsci/kfj127 ↗
41. Dugan, L. L., Gabrielsen, J. K., Yu, S. P., Lin, T. S. & Choi, D. W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3, 129–135 (1996).10.1006/nbdi.1996.0013 ↗
42. Daroczi, B., Kari, G., McAleer, M. F., Wolf, J. C., Rodeck, U. & Dicker, A. P. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin. Cancer Res. 12, 7086–7091 (2006).10.1158/1078-0432.CCR-06-0514 ↗
43. Quick, K. L., Ali, S. S., Arch, R., Xiong, C., Wonzniak, D. & Dugan, L. L. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol. Aging 29, 117–128 (2008).10.1016/j.neurobiolaging.2006.09.014 ↗
44. Misirkic, M. S., Todorovic-Markovic, B. M., Vucicevic, L. M., Janjetovic, K. D., Jokanovic, V. R., Dramicanin, M. D., Markovic, Z. M. & Trajkovic, V. S. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles. Biomaterial 30, 2319–2328 (2009).10.1016/j.biomaterials.2009.01.023 ↗
45. Xiao, L., Takada, H., Maeda, K., Haramoto, M. & Miwa, N. Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes. Biomed. Pharmacother. 59, 351–358 (2005).10.1016/j.biopha.2005.02.004 ↗
46. Tong, J., Zimmerman, M. C., Li, S. M., Yi, X., Luxenhofer, R., Jordan, R. & Kabanov, A. V. Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. Biomaterial 32, 3654–3665 (2011).10.1016/j.biomaterials.2011.01.068 ↗
47. Yin, J. J., Lao, F., Fu, P. P., Wamer, W. G., Zhao, Y. L., Wang, P. C., Qiu, Y., Sun, B. Y., Xing, G. M., Dong, J. Q., Liang, X. J. & Chen, C. Y. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterial 30, 611–621 (2009).10.1016/j.biomaterials.2008.09.061 ↗
48. Aust, S. D., Chignell, C. F., Bray, T. M., Kalyanaraman, B. & Mason, R. P. Free radicals in toxicology. Toxicol. Appl. Pharmacol. 120, 168–178 (1993).10.1006/taap.1993.1100 ↗
49. Loft, S. & Poulsen, H. E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74, 297–312 (1996).10.1007/BF00207507 ↗
50. Stadtman, E. R. & Berlett, B. S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10, 485–494 (1997).10.1021/tx960133r ↗
51. Chiang, L. Y., Lu, F. J. & Lin, J. T. Free-radical scavenging activity of water-soluble fullerenols. J. Chem. Soc. Chem. Commun. 1283–1284 (1995).10.1039/c39950001283 ↗
52. Ali, S. S., Hardt, J. I., Quick, K. L., Kim-Han, J. S., Erlanger, B. F., Huang, T. T., Epstein, C. J. & Dugan, L. L. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic. Biol. Med. 37, 1191–1202 (2004).10.1016/j.freeradbiomed.2004.07.002 ↗
53. Osuna, S., Swart, M. & Sola, M. On the mechanism of action of fullerene derivatives in superoxide dismutation. Chem. Eur. J. 16, 3207–3214 (2010).10.1002/chem.200902728 ↗
54. Kopylov, V. B. & Gavronskaya, Y. Y. Electronic and vibrational spectra of fullerenes in contact with oxygen. Russian J. Gen. Chem. 71, 1589–1592 (2001).10.1023/A:1013959205341 ↗
55. Bensasson, R. V., Brettreich, M., Frederiksen, J., Gottinger, H., Hirsch, A., Land, E. J., Leach, S., McGarvey, D. J. & Schonberger, H. Reactions of e(-)(aq), CO(2)(*)(-), HO(*), O(2)(*)(-) and O(2)((1)delta(g)) with a dendro[60]fullerene and C(60)[C(COOH)(2)](n) (n=2-6). Free Radical. Bio. Med. 29, 26–33 (2000).10.1016/S0891-5849(00)00287-2 ↗
56. Krusic, P. J., Wasserman, E., Keizer, P. N., Morton, J. R. & Preston, K. F. Radical reactions of c60. Science 254, 1183–1185 (1991).10.1126/science.254.5035.1183 ↗
57. Simonin, J. P. Solvent effects on osmotic second virial coefficient studied using analytic molecular models. Application to solutions of C60 fullerene. J. Phys. Chem. B 105, 5262–5270 (2001).10.1021/jp004077l ↗
58. Cagle, D. W., Kennel, S. J., Mirzadeh, S., Michael Alford, J. & Wilson, L. J. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc. Natl Acad. Sci. USA 96, 5182–5187 (1999).10.1073/pnas.96.9.5182 ↗
59. Okumura, M., Mikawa, M., Yokawa, T., Kanazawa, Y., Kato, H. & Shinohara, H. Evaluation of water-soluble metallofullerenes as MRI contrast agents. Acad. Radiol. 9, S495–S497 (2002).10.1016/S1076-6332(03)80274-X ↗
60. Mikawa, M., Kato, H., Okumura, M., Narazaki, M., Kanazawa, Y., Miwa, N. & Shinohara, H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug. Chem. 12, 510–514 (2001).10.1021/bc000136m ↗
61. Bolskar, R. D., Benedetoo, A. F., Husebo, L. O., Price, R. E., Jackson, E. F., Wallace, S. & Wilson, L. J. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J. Am. Chem. Soc. 125, 5471–5478 (2003).10.1021/ja0340984 ↗
62. Chen, C. Y., Xing, G. M., Wang, J. X., Zhao, Y. L., Li, B., Tang, J., Jia, G., Wang, T. C., Sun, J., Xing, L., Yuan, H., Gao, Y. X., Meng, H., Chen, Z., Zhao, F., Chai, Z. F. & Fang, X. H. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett. 5, 2050–2057 (2005).10.1021/nl051624b ↗
63. Yin, J. J., Lao, F., Meng, J., Fu, P. P., Zhao, Y. L., Xing, G. M., Gao, X. Y., Sun, B. Y., Wang, P. C., Chen, C. Y. & Liang, X. J. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol. Pharmacol. 74, 1132–1140 (2008).10.1124/mol.108.048348 ↗
64. Wang, J., Gu, F., Ding, T., Liu, X. L., Xing, G. M., Zhao, Y. L., Zhang, N. & Ma, Y. J. [Gd@C82(OH)22]n nanoparticles inhibit the migration and adhesion of glioblastoma cells. Oncol. Lett. 1, 771–775 (2010).10.3892/ol_00000135 ↗
65. Meng, J., Xing, M., Wang, Y. Z., Lu, J., Zhao, Y. L., Gao, X. Y., Wang, P. C., Jia, L. & Liang, X. J. Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis. Nanoscale 3, 4713–4719 (2011).10.1039/c1nr10898k ↗
66. Wang, J. X., Chen, C. Y., Li, B., Yu, H. W., Zhao, Y. L., Sun, J., Li, Y. F., Xing, G. M., Yuan, H., Tang, J., Chen, Z., Meng, H., Gao, Y. X., Ye, C., Chai, Z. F., Zhu, C. F., Ma, B. C., Fang, X. H. & Wan, L. J. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem. Pharmacol. 71, 872–881 (2006).10.1016/j.bcp.2005.12.001 ↗
67. Toyokuni, S., Okamoto, K., Yodoi, J. & Hiai, H. Persistent oxidative stress in cancer. Febs. Lett. 358, 1–3 (1995).10.1016/0014-5793(94)01368-B ↗
68. Pelicano, H., Carney, D. & Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7, 97–110 (2004).10.1016/j.drup.2004.01.004 ↗
69. Yang, D., Zhao, Y. L., Guo, H., Li, Y. N., Tewary, P., Xing, G. M., Hou, W., Oppenheim, J. J. & Zhang, N. [Gd@C82(OH)22]n nanoparticles induce dendritic cell maturation and activate Th1 immune responses. Acs Nano 4, 1178–1186 (2010).10.1021/nn901478z ↗
70. Kang, S., Zhou, G. Q., Yang, P., Liu, Y., Sun, B. Y., Huynh, T., Meng, H., Zhao, L. N., Xing, G. M., Chen, C. Y., Zhao, Y. L. & Zhou, R. H. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Proc. Natl Acad. Sci. USA 109, 15431–15436 (2012).10.1073/pnas.1204600109 ↗
71. Zuo, G., Huang, Q., Wei, G., Zhou, R. & Fang, H. Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. ACS Nano 4, 7508–7514 (2010).10.1021/nn101762b ↗
72. Ge, C. C., Du, J. F., Zhao, L. N., Wang, L. M., Liu, Y., Li, D. H., Yang, Y. L., Zhou, R. H., Zhao, Y. L., Chai, Z. F. & Chen, C. Y. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl Acad. Sci. USA 108, 16968–16973 (2011).10.1073/pnas.1105270108 ↗
73. Liang, X. J., Meng, H., Wang, Y. Z., He, H. Y., Meng, J., Lu, J., Wang, P. C., Zhao, Y. L., Gao, X. Y., Sun, B. Y., Chen, C. Y., Xing, G. M., Shen, D. W., Gottesman, M. M., Wu, Y., Yin, J. J. & Jia, L. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc. Natl Acad. Sci. USA 107, 7449–7454 (2010).10.1073/pnas.0909707107 ↗
74. Li, J., Zhang, M. Y., Sun, B. Y., Xing, G. M., Song, Y., Guo, H. L., Chang, Y., Ge, Y. H. & Zhao, Y. L. Separation and purification of fullerenols for improved biocompatibility. Carbon. NY 50, 460–469 (2011).10.1016/j.carbon.2011.08.073 ↗
75. Raebiger, J. W. & Bolskar, R. D. Improved production and separation process for gadolinium metallofullerenes. J. Phys. Chem. C 112, 6605–6612 (2008).10.1021/jp076437b ↗
76. Akiyama, K., Hamano, T., Nakanishi, Y., Takeuchi, E., Noda, S., Wang, Z. Y., Kubuki, S. & Shinohara, H. Non-HPLC rapid separation of metallofullerenes and empty cages with TiCl4 Lewis acid. J. Am. Chem. Soc. 134, 9762–9767 (2012).10.1021/ja3030627 ↗
77. Pagona, G., Mountrichas, G., Rotas, G., Karousis, N., Pispas, S. & Tagmatarchis, N. Properties, applications and functionalization of carbon nanohorns. Int. J. Nanotechnol. 6, 176–195 (2009).10.1504/IJNT.2009.021715 ↗
78. Brandao, L., Passeira, C., Gattia, D. M. & Mendes, A. Use of single wall carbon nanohorns in polymeric electrolyte fuel cells. J. Mater. Sci. 46, 7198–7205 (2011).10.1007/s10853-010-4638-6 ↗
79. Izadi-Najafabadi, A., Yamada, T., Futaba, D. N., Yudasaka, M., Takagi, H., Hatori, H., Iijima, S. & Hata, K. High-power supercapacitor electrodes from single-walled carbon nanohorn/nanotube composite. Acs Nano 5, 811–819 (2011).10.1021/nn1017457 ↗
80. Zhao, Y., Li, J. X., Ding, Y. H. & Guan, L. H. Single-walled carbon nanohorns coated with Fe2O3 as a superior anode material for lithium ion batteries. Chem. Commun. 47, 7416–7418 (2011).10.1039/c1cc12171e ↗
81. Zhu, S. Y., Liu, Z. Y., Zhang, W., Han, S., Hu, L. Z. & Xu, G. B. Nucleic acid detection using single-walled carbon nanohorns as a fluorescent sensing platform. Chem. Commun. 47, 6099–6101 (2011).10.1039/c1cc10952a ↗
82. Li, J., He, Y. J., He, Z., Zeng, P. & Xu, S. K. Synthesis of NaYF4:Yb,Er/single-walled carbon nanohorns nanocomposite and its application as cells label. Anal. Biochem. 428, 4–6 (2012).10.1016/j.ab.2012.05.025 ↗
83. Liu, Y., Brown, C. M., Neumann, D. A., Geohegan, D. B., Puretzky, A. A., Rouleau, C. M., Hu, H., Styers-Barnett, D., Krasnov, P. O. & Yakobson, B. I. Metal-assisted hydrogen storage on Pt-decorated single-walled carbon nanohorns. Carbon. NY 50, 4953–4964 (2012).10.1016/j.carbon.2012.06.028 ↗
84. Niu, B., Xu, W., Guo, Z. D., Zhou, N. Z., Liu, Y., Shi, Z. J. & Lian, Y. F. Controllable deposition of platinum nanoparticles on single-wall carbon nanohorns as catalyst for direct methanol fuel cells. J. Nanosci. Nanotechnol. 12, 7376–7381 (2012).10.1166/jnn.2012.6569 ↗
85. Pagona, G., Zervaki, G. E., Sandanayaka, A. S. D., Ito, O., Charalambidis, G., Hasobe, T., Coutsoleos, A. G. & Tagmatarchis, N. Carbon nanohorn-porphyrin dimer hybrid material for enhancing light-energy conversion. J. Phys. Chem. C 116, 9439–9449 (2012).10.1021/jp302178q ↗
86. Yuge, R., Manako, T., Nakahara, K., Yasui, M., Iwasa, S. & Yoshitake, T. The production of an electrochemical capacitor electrode using holey single-wall carbon nanohorns with high specific surface area. Carbon NY 50, 5569–5573 (2012).10.1016/j.carbon.2012.08.005 ↗
87. Zhang, L. W., Zheng, N., Gao, A., Zhu, C. M., Wang, Z. Y., Wang, Y., Shi, Z. J. & Liu, Y. A robust fuel cell cathode catalyst assembled with nitrogen-doped carbon nanohorn and platinum nanoclusters. J. Power Sources 220, 449–454 (2012).10.1016/j.jpowsour.2012.08.009 ↗
88. Zhu, S. Y., Liu, Z. Y., Hu, L. Z., Yuan, Y. L. & Xu, G. B. Turn-on fluorescence sensor based on single-walled-carbon-nanohorn-peptide complex for the detection of thrombin. Chem. Eur. J. 18, 16556–16561 (2012).10.1002/chem.201201468 ↗
89. Muralkami, T., Ajima, K., Miyawaki, J., Yudasaka, M., Iijima, S. & Shiba, K. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro. Mol. Pharmaceut. 1, 399–405 (2004).10.1021/mp049928e ↗
90. Ajima, K., Yudasaka, M., Murakami, T., Maigne, A., Shiba, K. & Ijima, S. Carbon nanohorns as anticancer drug carriers. Mol. Pharmaceut. 2, 475–480 (2005).10.1021/mp0500566 ↗
91. Xu, J. X., Yudasaka, M., Kouraba, S., Sekido, M., Yamamoto, Y. & Iijima, S. Single wall carbon nanohorn as a drug carrier for controlled release. Chem. Phys. Lett. 461, 189–192 (2008).10.1016/j.cplett.2008.06.077 ↗
92. Tahara, Y., Miyawaki, J., Zhang, M. F., Yang, M., Waga, I., Iijima, S., Irie, H. & Yudasaka, M. Histological assessments for toxicity and functionalization-dependent biodistribution of carbon nanohorns. Nanotechnology 22, 265106 (2011).10.1088/0957-4484/22/26/265106 ↗
93. Murakami, T. & Tsuchida, K. Recent advances in inorganic nanoparticle-based drug delivery systems. Mini-Rev. Med. Chem. 8, 175–183 (2008).10.2174/138955708783498078 ↗
94. Zhang, M. F., Yudasaka, M., Ajima, K., Miyawaki, A. & Lijima, S. Light-assisted oxidation of single-wall carbon nanohorns for abundant creation of oxygenated groups that enable chemical modifications with proteins to enhance biocompatibility. Acs Nano 1, 265–272 (2007).10.1021/nn700130f ↗
95. Xu, J. X., Zhang, M. F., Nakamura, M., Iijima, S. & Yudasaka, M. Double oxidation with oxygen and hydrogen peroxide for hole-forming in single wall carbon nanohorns. Appl. Phys. A 100, 379–383 (2010).10.1007/s00339-010-5849-z ↗
96. Desai, N. & Hubbell, J. Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials. Biomaterial 12, 144–153 (1991).10.1016/0142-9612(91)90193-E ↗
97. Du, H., Chandaroy, P. & Hui, S. Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim. Biophys. Acta 1326, 236–248 (1997).10.1016/S0005-2736(97)00027-8 ↗
98. Xu, J. X., Iijima, S. & Yudasaka, M. Appropriate PEG compounds for dispersion of single wall carbon nanohorns in salted aqueous solution. Appl. Phys. A 99, 15–21 (2010).10.1007/s00339-010-5582-7 ↗
99. Muralkami, T., Fan, J., Yudasaka, M., Iijima, S. & Shiba, K. Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate. Mol. Pharmaceut. 3, 407–414 (2006).10.1021/mp060027a ↗
100. Matsumura, S., Ajima, K., Yudasaka, M., Iijima, S. & Shiba, K. Dispersion of cisplatin-loaded carbon nanohorns with a conjugate comprised of an artificial peptide aptamer and polyethylene glycol. Mol. Pharmaceut. 4, 723–729 (2007).10.1021/mp070022t ↗